eff Cancer Research Results
eff, efficacy: Click to Expand ⟱
| Source: |
| Type: |
Power to enhance an anti cancer effect
|
GC, Gastric Adenocarcinoma: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
| - |
vitro+vivo, |
GC, |
HGC27 |
|
|
|
- |
in-vitro, |
GC, |
AGS |
|
|
|
- |
in-vitro, |
GC, |
BGC-823 |
|
|
|
- |
in-vitro, |
GC, |
SGC-7901 |
|
|
|
- |
in-vitro, |
Nor, |
HEK293 |
|
|
|
TumCP↓, TumCCA↑, Casp↑, Apoptosis↑, TrxR1↓, ROS↑, eff↓, eff↑, PI3K↓, Akt↓, TumCG↓, cl‑PARP↑, cl‑Casp3↑, cl‑Casp9↑, cl‑Casp8↑, Bcl-2↓, Bcl-xL↓, Mcl-1↓, XIAP↓, survivin↓, TumVol↓, TumW↓, Weight∅, toxicity↓, Ki-67↓, other↝,
| - |
vitro+vivo, |
GC, |
AGS |
|
|
|
- |
vitro+vivo, |
GC, |
HGC27 |
|
|
|
ROS↑, NRF2↑, eff↓, eff↑,
TumCCA↑, CDK2↓, P53↑, selectivity↑, MMP↓, DNAdam↑, cl‑PARP↑, mt-ROS↑, eff↓, survivin↓,
| - |
in-vitro, |
GC, |
SGC-7901 |
|
|
|
- |
in-vitro, |
GC, |
NA |
|
|
|
TrxR1↓, ROS↑, ER Stress↑, mtDam↑, selectivity↑, NO↑, TumCCA↑, mt-ROS↑, Casp9↑, Bcl-2↓, Bcl-xL↓, cl‑PARP↑, eff↓, lipid-P↑,
TumCP↓, Apoptosis↑, TumCCA↑, CycB/CCNB1↑, P21↑, p‑H3↑, p‑AMPK↑, eff↓, MMP↓, Cyt‑c↑, ROS↑, eff↓,
| - |
in-vitro, |
GC, |
BGC-823 |
|
|
|
- |
in-vitro, |
GC, |
SGC-7901 |
|
|
|
- |
in-vitro, |
Nor, |
GES-1 |
|
|
|
selectivity↑, TumCP↓, TumCD↑, ROS↑, MMP↓, Casp↑, Cyt‑c↑, Endon↑, AIF↑, eff↓, ChemoSen↑, TumCCA↑, GSH/GSSG↓, lipid-P↑,
Showing Research Papers: 1 to 6 of 6
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 6
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
GSH/GSSG↓, 1, lipid-P↑, 2, NRF2↑, 1, ROS↑, 5, mt-ROS↑, 2, TrxR1↓, 2,
Mitochondria & Bioenergetics(tgid=3) ⓘ
AIF↑, 1, MMP↓, 3, mtDam↑, 1, XIAP↓, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
p‑AMPK↑, 1,
Cell Death(tgid=5) ⓘ
Akt↓, 1, Apoptosis↑, 2, Bcl-2↓, 2, Bcl-xL↓, 2, Casp↑, 2, cl‑Casp3↑, 1, cl‑Casp8↑, 1, Casp9↑, 1, cl‑Casp9↑, 1, Cyt‑c↑, 2, Endon↑, 1, Mcl-1↓, 1, survivin↓, 2, TumCD↑, 1,
Transcription & Epigenetics(tgid=7) ⓘ
p‑H3↑, 1, other↝, 1,
Protein Folding & ER Stress(tgid=8) ⓘ
ER Stress↑, 1,
DNA Damage & Repair(tgid=10) ⓘ
DNAdam↑, 1, P53↑, 1, cl‑PARP↑, 3,
Cell Cycle & Senescence(tgid=11) ⓘ
CDK2↓, 1, CycB/CCNB1↑, 1, P21↑, 1, TumCCA↑, 5,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
PI3K↓, 1, TumCG↓, 1,
Migration(tgid=13) ⓘ
Ki-67↓, 1, TumCP↓, 3,
Angiogenesis & Vasculature(tgid=14) ⓘ
NO↑, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
ChemoSen↑, 1, eff↓, 7, eff↑, 2, selectivity↑, 3,
Clinical Biomarkers(tgid=22) ⓘ
Ki-67↓, 1,
Functional Outcomes(tgid=23) ⓘ
toxicity↓, 1, TumVol↓, 1, TumW↓, 1, Weight∅, 1,
Total Targets: 49
Pathway results for Effect on Normal Cells:
Total Targets: 0
Scientific Paper Hit Count for: eff, efficacy
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:28 Cells:% prod#:% Target#:961 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page